Skip to main content
. Author manuscript; available in PMC: 2014 Aug 18.
Published in final edited form as: J Neurochem. 2012 Aug 3;122(6):1203–1210. doi: 10.1111/j.1471-4159.2012.07860.x

Fig. 4.

Fig. 4

Impairment of neuronal viability following disruption of proteasome degradation pathway. (a) SN4741 cells were treated with MG132 (2.5 μM), MPP+ (25 μM) or rotenone (100 nM) treatment for 24 hours. Cell viability was measured by WST-1 assay. The experiments were repeated 4 times. (b) SN4741 cells were treated as in (a) and than stained with PI (Prodidium Iodide) and DAPI. The experiments were repeated 4 times. Bar=200 μm. *, p<0.01.